glp 1 select trial Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the 3 Takeaways from the Landmark

GLP-1s (short for glucagon-like peptide-1 receptor agonists) are medications that mimic a natural hormone in the body that helps to regulate blood sugar levels and appetite

Backed by U.S

It can lead to a variety of uncomfortable symptoms, including: Nausea Vomiting Feeling full after just a few bites Abdominal bloating or pain Poor appetite Heartburn Feeling full for a long time after eating These symptoms can range from mild to severe, and in some cases, they can significantly disrupt daily life

J Med Life (2015) 8(Spec Iss 4):3016

These effects contribute to the medication's weight loss efficacy, with clinical trials showing weight reductions that vary by dose and indication, generally ranging from 5-15% in type 2 diabetes and 15-20% in obesity at the highest doses

Specified side effects include inflammation of your pancreas (pancreatitis)